Gland Pharma to invest $21 million in US subsidiary for Novelstar Pharma stake

Gland Pharma's board has approved a $21 million investment in its US subsidiary, Gland Pharma USA Inc. The subsidiary will use these funds to acquire a 60% stake in the newly incorporated Novelstar Pharma Inc. The investment aims to expand Gland Pharma's business operations.